BamSEC and AlphaSense Join Forces
Learn More

IDEXX Laboratories Inc.

NASDAQ: IDXX    
Share price (5/16/25): $518.10    
Market cap (5/16/25): $41.7 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.56
from 10-K 15 pages Form of Change in Control Agreement
12/34/56
EX-10.53
from 10-K 31 pages IDEXX Deferred Compensation Plan Effective Date December 6, 2024
12/34/56
EX-10.30
from 10-K 2 pages IDEXX Laboratories, Inc. Executive Incentive Plan Summary of Bonus Determination Process as of Performance Year Beginning 1/1/2025
12/34/56
EX-10.18
from 10-K 4 pages Certain Confidential Information Contained in This Document, Marked by Asterisks [**], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Amendment No. 7
12/34/56
EX-10.10
from 10-K 4 pages Certain Confidential Information Contained in This Document, Marked by Asterisks [**], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. Amendment No. 9
12/34/56
EX-10.2
from 10-Q 16 pages Form of Change in Control Agreement
12/34/56
EX-10.1
from 10-Q 45 pages Third Amended and Restated Executive Employment Agreement
12/34/56
EX-10.5
from 10-Q ~5 pages Employee Stock Option Agreement Granted Under Idexx Laboratories, Inc. 2009 Stock Incentive Plan
12/34/56
EX-10.4
from 10-Q 45 pages Third Amended and Restated Executive Employment Agreement
12/34/56
EX-10.3
from 10-Q 16 pages Form of Change in Control Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Suspension of Rights Agreement
12/34/56
EX-10.1
from 8-K 8 pages Consulting Agreement
12/34/56
EX-10.50
from 10-K 13 pages Employee Leveraged Restricted Stock Unit Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.28
from 10-K 2 pages Idexx Laboratories, Inc. Executive Incentive Plan Summary of Bonus Determination Process as of Performance Year Beginning 1/1/2024
12/34/56
EX-10.1
from 10-Q 2 pages Certain Confidential Information Contained in This Document, Marked by Asterisks [**], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed. July 28, 2023
12/34/56
EX-10.27
from 10-K 2 pages Idexx Laboratories, Inc. Executive Incentive Plan Summary of Bonus Determination Process as of Performance Year Beginning 1/1/2023
12/34/56
EX-10.1
from 10-Q 9 pages Confidential Information, Work Product, and Restrictive Covenant Agreement
12/34/56
EX-10.44
from 10-K 6 pages CEO Stock Option Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.43
from 10-K 7 pages CEO Restricted Stock Unit Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56
EX-10.42
from 10-K 2 pages Restricted Stock Unit Agreement Granted Under Idexx Laboratories, Inc. 2018 Stock Incentive Plan
12/34/56